Since its inception, Rigaku has been at the forefront of analytical and industrial instrumentation technology. Today, with hundreds of major innovations to their credit, the Rigaku Group of Companies ...

TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA ...

The portable Rigaku CQL Narc-ID Raman analyzer, operating at 1064 nm, offers preliminary identification capabilities for narcotics, their precursor substances, and adulterants, effective even at ...

Left: Keitaro Iwaki, President & Representative Director, SPERA PHARMA; Right: Jun Kawakami, President & CEO, Rigaku TOKYO, April 17, 2025--(BUSINESS WIRE)--Rigaku Corporation, a Group company of ...